ERA Registry Figure of the month Patient survival on dialysis and kidney transplantation

Figure 1:

Patient survival for incident dialysis patients by modality (haemodialysis or peritoneal dialysis) from day 91 (cohort 2013–2017) (left panel) and for first-time kidney transplant recipients by donor type (deceased or living) from day of transplantation (cohort 2013–2017) (right panel).

Source: Boenink et al. CKJ 2024, https://doi.org/10.1093/ckj/sfae405, Figs. 13 and 14.

Explanation: The unadjusted 5-year survival probability was similar for patients starting haemodialysis (41.3%) and for patients starting peritoneal dialysis (41.5%). In patients receiving a first kidney transplant, the unadjusted 5-year survival was higher for those who received a living donor (94.2%) than for those who received a deceased donor (85.8%).

Open in new tabDownload slide

ACKNOWLEDGEMENTS

The ERA Registry would like to thank the patients and staff of all the dialysis and transplant units who have contributed data via their national and regional renal registries.

CONFLICT OF INTEREST STATEMENT

A.O. is one of the former Editors-in-Chief of CKJ and has received support for medical writing from Astellas and Open Health Group; grants from Sanofi; consultancy or speaker fees or travel support from Advicciene, Astellas, Astrazeneca, Amicus, Amgen, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Menarini, Kyowa Kirin, Alexion, Idorsia, Chiesi, Otsuka, Novo-Nordisk and Vifor Fresenius Medical Care Renal Pharma; and is Director of the Catedra Mundipharma-UAM of diabetic kidney disease and the Catedra Astrazeneca-UAM of chronic kidney disease and electrolytes. V.S.S. received research funding grants from the European Renal Association. A.K. has no conflicts of interest to disclose.